In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects

[1] Montanaro F(2009)Survival of pleural malignant mesothelioma in Italy: a population-based study Int J Cancer 124 201-207

[2] Rosato R(2002)Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis Lung Cancer 38 111-121

[3] Gangemi M(2008)Systemic treatments for mesothelioma: standard and novel Curr Treat Options Oncol 9 171-179

[4] Roberti S(2007)Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma (Review) Cochrane Database Syst Rev 2 1-17

[5] Ricceri F(2008)Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810) Lung Cancer 60 259-263

[6] Merler E(2006)Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma Lung Cancer 53 367-374

[7] Gennaro V(1996)Synergistic interaction between cisplatin and gemcitabine in vitro Clin Cancer Res 2 521-530

[8] Romanelli A(1999)Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures Anticancer Drugs 10 445-452

[9] Chellini E(2004)Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance Lung Cancer 45S S37-S43

[10] Pascucci C(2002)Cancer testis antigens expression in mesothelioma Br J Cancer 86 979-982

[1] Montanaro F(2009)Survival of pleural malignant mesothelioma in Italy: a population-based study Int J Cancer 124 201-207

[2] Rosato R(2002)Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis Lung Cancer 38 111-121

[3] Gangemi M(2008)Systemic treatments for mesothelioma: standard and novel Curr Treat Options Oncol 9 171-179

[4] Roberti S(2007)Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma (Review) Cochrane Database Syst Rev 2 1-17

[5] Ricceri F(2008)Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810) Lung Cancer 60 259-263

[6] Merler E(2006)Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma Lung Cancer 53 367-374

[7] Gennaro V(1996)Synergistic interaction between cisplatin and gemcitabine in vitro Clin Cancer Res 2 521-530

[8] Romanelli A(1999)Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures Anticancer Drugs 10 445-452

[9] Chellini E(2004)Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance Lung Cancer 45S S37-S43

[10] Pascucci C(2002)Cancer testis antigens expression in mesothelioma Br J Cancer 86 979-982